Transplant Infectious Disease

Papers
(The H4-Index of Transplant Infectious Disease is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
89
55
Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant39
Histoplasma capsulatum tenosynovitis: An unusual presentation in a kidney transplant recipient39
Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?35
1,3‐β‐D‐glucan testing for nocardiosis in solid organ transplant recipients32
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review32
Successful treatment of Rhodococcus lung abscess and empyema thoracis in a heart transplant recipient30
SARS‐CoV‐2 seropositivity in renal transplant patients administered intravenous immunoglobulin29
Comparative 3‐Year Allograft Outcomes for Recipients of Kidneys From SARS‐CoV‐2 NAT‐Positive Donors27
Nitazoxanide for Enterocytozoon bieneusi intestinal microsporidiosis26
Impact of Donor Radiographic Pneumonia on Posttransplant Recipient Outcomes and Microbiology26
Healthcare resource utilization of maribavir versus investigator‐assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior tre26
Outcome of Liver Transplantation for Critically Ill Acute on Chronic Liver Failure Recipients Complicated With Pretransplant Invasive Pulmonary Aspergillosis26
A Comparison of a Solid Organ Transplant Population‐Specific Antibiogram With the Hospital‐Wide Antibiogram25
Disseminated Acanthamoeba Infection After Heart‐Lung Transplantation25
Hospital‐Acquired Respiratory Viral Infections (HA‐RVIs) Over 10 Years Disproportionally Affect the Immunocompromised25
Perspectives on biovigilance and transmission of infection of donor origin in deceased organ donation—The evolving scenario in the United Kingdom24
Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient23
Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study21
Immunocompromised Host Infectious Diseases: A Recommended Educational Content Outline for Advanced Practice Providers21
0.13554787635803